Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Emergent anthrax vaccine receives Singapore HSA approval
BioThrax is indicated to prevent anthrax infection and is also indicated for the active immunization of adults who are at high risk of exposure to anthrax. BioThrax is
BioThrax is indicated to prevent anthrax infection and is also indicated for the active immunization of adults who are at high risk of exposure to anthrax. BioThrax is
The pRED French R&D Institute will be managed by a Roche academic team which will be in charge of building new research networks with French academic partners, leveraging
InVasc’s INV-144 is a combination drug of losartan and alpha Lipoic Acid (ALA), which is used to slow down the progression of chronic kidney disease (CKD) in patients
Following the acquisition, the plant will be licensed to produce N-acetylgalactosamine 6-sulfatase (GALNS) by 2015. BioMarin CEO Jean-Jacques Bienaime said they believe that additional manufacturing capabilities beyond their
Glybera is used to treat patients with the genetic disorder lipoprotein lipase deficiency (LPLD). AMT CEO Jorn Aldag said they believe that there is an indication from the
Earlier in February, Pfizer said it would close operations at the site. The US based drug maker’s intent was to outsource some R&D activities and colleagues at the
SBC-102, which is under clinical trials, is a recombinant human lysosomal acid lipase enzyme responsible for the breakdown of cholesteryl esters and triglycerides. Synageva R&D CMO and head
The company had provided only non-GLP services focused on early stage research and discovery. Aragen Bioscience specializes in recombinant cell line and hybridoma development, cell culture and protein
Zyclara cream is indicated for the treatment of actinic keratosis (AK) on the face and scalp. Meda CEO Anders Lonner said Zyclara will strengthen Meda’s dermatology franchise in
Under the agreement, Evotec will use PhosphoScout platform for discovery of protein-phosphorylation’s that predict favorable dosage and efficacy of targeted cancer drugs in patients. Evotec’s PhosphoScout platform uses